Life Biosciences LLC, the longevity startup founded by Harvard researcher David Sinclair and funded by WeWork’s Adam Neumann, is ramping up an expansion of its bid to become the world’s largest company dedicated to antiaging drugs.

Launched publicly in April, the Cambridge, Mass.- based company has six subsidiaries across four continents. Adding to that, it just acquired Lua Technologies Inc., a health-care communications company, to power Life Biosciences’ research collaboration platform. No financial terms of the acquisition...